NCT01764880View on ClinicalTrials.gov

SST0001 (Roneparstat) in Advanced Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Multiple Myeloma
Interventions
DRUG

SST0001 (Roneparstat)

SST0001 once daily for 5 or 10 days in a cycle of 28 days.

Trial Locations (5)

12100

S.C. Ematologia, ASO S. Croce e Carle - Cuneo, Cuneo

24127

USC Ematologia, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo

70124

U.O. Ematologia con Trapianto, Dipartimento dell'Emergenza e dei Trapianti di Organi, Bari

97080

Manik Chatterjee, Würzburg

Unknown

Division of Hematology, Chaim Sheba Medical Center, Tel Litwinsky

All Listed Sponsors
lead

Sigma Tau Research Switzerland SA

INDUSTRY

NCT01764880 - SST0001 (Roneparstat) in Advanced Multiple Myeloma | Biotech Hunter | Biotech Hunter